Related Experiment Video
Updated: Mar 20, 2026
08:59
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
3.2K
Deciphering the missing links between Friedreich ataxia and multiple sclerosis for targeted drug development
Faith A A Kwa1, Sara Anjomani-Virmouni2, Zenouska Ramchunder2
1Department of Biomedical, Health and Exercise Sciences, School of Health Sciences, Swinburne University of Technology, Melbourne, VIC, Australia.
Drug Discovery Today
|March 18, 2026
Summary
Friedreich ataxia and multiple sclerosis share underlying molecular mechanisms like iron dysregulation and neuroinflammation. Understanding these common pathways in neurodegenerative diseases could lead to new diagnostic tools and treatments.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Neurodegenerative diseases (NDDs) like Friedreich ataxia (FA) and multiple sclerosis (MS) exhibit progressive neurodegeneration.
- FA and MS, despite different causes, share overlapping molecular pathologies.
Purpose of the Study:
- To explore shared pathological features and disease mechanisms in FA and MS.
- To highlight how understanding these shared pathways can inform diagnostics and therapeutics.
Main Methods:
- Comparative transcriptomic analyses.
- Review of existing research on molecular mechanisms in FA and MS.
Main Results:
- Identified shared mechanisms including iron and lipid dysregulation, mitochondrial dysfunction, oxidative stress, and neuroinflammation.
- Transcriptomic data reveals common disease pathways.
Conclusions:
- Delineating shared pathways in FA and MS offers insights into potential biomarkers and therapeutic targets.
- Mechanism-based interventions and drug repurposing are potential strategies for NDDs.
